Platinum Partners
Newswire Biotechnology News
Data for SemBioSys' APO AI(Milano) to be presented at the American College of Cardiology's 59th Annual Scientific Session
TSX symbol: SBS CALGARY, March 12 /CNW/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today
Fri, 12 Mar 2010 07:00:00 EST
Spectral announces presentations at the 8th Annual World Congress on Trauma, Shock, Inflammation and Sepsis focusing on the role of endotoxin
TORONTO, March 12 /CNW/ - Spectral Diagnostics Inc. (TSX:SDI), a company developing products for the treatment of sepsis, today announced that the 8th Annual World Congress on Trauma, Shock, Inflammation and Sepsis in Munich, Germany from March 9-13, 2010 will feature a key scientific symposium
Fri, 12 Mar 2010 07:00:00 EST
ConjuChem retains Bloom Burton & Co.
MONTREAL, March 11 /CNW/ - ConjuChem Biotechnologies Inc. (TSX: CJB) ("ConjuChem" or the "Company")announced that the Committee of independent Board members mandated to explore and evaluate all strategic alternatives have elected to engage Bloom Burton & Co., a leading Canadian healthcare
Thu, 11 Mar 2010 12:44:00 EST
Alberta companies delivering new products to the Conventional Energy marketplace
Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts Conventional Energy seminar EDMONTON, March 11 /CNW/ - Today at ACAMP's latest seminar, Alberta's
Thu, 11 Mar 2010 11:30:00 EST
Technoparc Montréal in Cannes to present the Largest Eco-Innovation Zone in Canada
MONTREAL, March 11 /CNW Telbec/ - Mario Monette, President and Chief Executive Officer of Technoparc Montréal, will be in Cannes next week for MIPIM, the world's premier real estate summit, to raise investors' interest in the International Eco-Innovation Zone, the third development phase of
Thu, 11 Mar 2010 09:15:00 EST
Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs
TORONTO, March 11 /CNW/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered into two definitive license agreements with University Health Network (UHN) and The Hospital for Sick Children (SickKids)
Thu, 11 Mar 2010 07:00:00 EST
Spectral announces 2009 financial results
TORONTO, March 11 /CNW/ - Spectral Diagnostics Inc. (TSX:SDI) today announced its operational highlights and financial results for the fiscal year ended December 31, 2009. "This year, Spectral successfully transitioned from a purely diagnostics
Thu, 11 Mar 2010 07:00:00 EST
Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project
<<
Thu, 11 Mar 2010 00:02:00 EST
Health Canada issued a NPN to Advitech for Dermylex
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TSX VENTURE EXCHANGE: AVI
Wed, 10 Mar 2010 17:15:00 EST
Bio-Processing Alliance Inc. Launches Comprehensive Consulting Business
TORONTO, March 10 /CNW/ - Bio-Processing Alliance Inc. announces its official launch of business. BPAI is a biologics drug development 'think tank' providing consultative direction and support in the management of complex biologics programs from concept, through to development and
Wed, 10 Mar 2010 16:32:00 EST
Spectral appoints two new board members
TORONTO, March 10 /CNW/ - Spectral Diagnostics Inc. (TSX:SDI), a company developing products for the treatment of sepsis, today announced the appointment of Mr. Kevin Giese, President, CEO and Director of BioMS Medical and Mr. Laine Woollard, QC, Senior Legal Counsel of TEC Edmonton, to the
Wed, 10 Mar 2010 13:00:00 EST
YM BioSciences closes US$17.5 million financing
MISSISSAUGA, ON, March 10 /CNW/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), today announced that it has closed its previously announced "registered direct" offering of 14,583,000 million units at an issue price of US $1.20 for gross proceeds of approximately US $17.5 million. Each unit
Wed, 10 Mar 2010 13:00:00 EST